Alpha Cognition Cash on Hand 2020-2024 | ACOG
Alpha Cognition cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Alpha Cognition Annual Cash on Hand
(Millions of US $) |
| 2023 |
$1 |
| 2022 |
$2 |
| 2021 |
$11 |
| 2020 |
$6 |
| 2019 |
$5 |
Alpha Cognition Quarterly Cash on Hand
(Millions of US $) |
| 2024-06-30 |
$1 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$1 |
| 2023-09-30 |
$1 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$4 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$4 |
| 2022-06-30 |
$6 |
| 2022-03-31 |
$9 |
| 2021-12-31 |
$11 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$7 |
| 2020-12-31 |
$6 |
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
$5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
